Ceruloplasmin— 510(k) K161508
Substantially EquivalentBeckman Coulter Ireland, Inc.
FDA 510(k) clearance K161508 for Ceruloplasmin, Substantially Equivalent on 2017-01-09. Applicant: Beckman Coulter Ireland, Inc.. Device class: 2.
Clearance details
- Applicant
- Beckman Coulter Ireland, Inc.
- Product code
- Code DDB
- Device class
- Class 2
- Regulation
- 21 CFR 866.5210
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Co. Clare, IE
Recent devices under product code DDB
view allMore clearances from Beckman Coulter Ireland, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.